With the rise of emerging therapeutic modalities, such as complex biologics, immune cell therapies and gene therapies, how are CDMOs adapting their fill/finish capabilities to meet evolving client needs
GHK-Cu is a small copper-binding tripeptide (340 Daltons) discovered by Loren Pickart in 1973
doi:10.1016/j.toxlet.2013.06.229 Silva MM, Da Fonseca CO, Moura-Neto R, Carvalho JF, Quirico-Santos T, Carvalho MG (2013) Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy
E.McNeelD
Refrain from use if you are at risk of psychiatric, liver, heart, or thyroid disease, diabetes, anxiety, depression, seizure disorder, pernicious anemia, or difficult urination due to enlarged prostate
Porter, A